Equities analysts expect Stericycle Inc (NASDAQ:SRCL) to post $1.01 earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Seven analysts have made estimates for Stericycle’s earnings, with the lowest EPS estimate coming in at $0.96 and the highest estimate coming in at $1.05. Stericycle posted earnings of $1.10 per share during the same quarter last year, which would suggest a negative year over year growth rate of 8.2%. The company is scheduled to report its next earnings report on Wednesday, November 14th.
According to Zacks, analysts expect that Stericycle will report full-year earnings of $4.43 per share for the current financial year, with EPS estimates ranging from $4.40 to $4.47. For the next financial year, analysts anticipate that the business will post earnings of $4.60 per share, with EPS estimates ranging from $4.50 to $4.68. Zacks’ earnings per share calculations are a mean average based on a survey of research analysts that follow Stericycle.
Stericycle (NASDAQ:SRCL) last announced its quarterly earnings data on Thursday, August 2nd. The business services provider reported $1.17 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.13 by $0.04. Stericycle had a return on equity of 14.04% and a net margin of 5.03%. The firm had revenue of $883.30 million for the quarter, compared to analyst estimates of $896.62 million. During the same quarter in the prior year, the company posted $1.15 earnings per share. Stericycle’s quarterly revenue was down 3.7% on a year-over-year basis.
A number of brokerages recently weighed in on SRCL. Jefferies Financial Group set a $75.00 price objective on Stericycle and gave the stock a “buy” rating in a report on Thursday, August 2nd. BidaskClub raised Stericycle from a “buy” rating to a “strong-buy” rating in a report on Tuesday, July 31st. Zacks Investment Research lowered Stericycle from a “buy” rating to a “hold” rating in a report on Monday, July 16th. BMO Capital Markets reissued a “hold” rating and issued a $71.00 target price on shares of Stericycle in a report on Thursday, July 12th. Finally, Barrington Research reissued a “buy” rating on shares of Stericycle in a report on Friday, June 1st. Two investment analysts have rated the stock with a sell rating, four have assigned a hold rating and four have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $71.71.
In other Stericycle news, Director Mark C. Miller sold 65,314 shares of the company’s stock in a transaction on Thursday, July 5th. The stock was sold at an average price of $65.08, for a total value of $4,250,635.12. Following the sale, the director now owns 224,052 shares of the company’s stock, valued at $14,581,304.16. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Daniel Ginnetti sold 5,000 shares of the company’s stock in a transaction on Wednesday, August 1st. The shares were sold at an average price of $70.00, for a total value of $350,000.00. The disclosure for this sale can be found here. Insiders sold 170,601 shares of company stock worth $11,153,063 in the last three months. 3.50% of the stock is owned by corporate insiders.
A number of institutional investors have recently bought and sold shares of SRCL. Federated Investors Inc. PA lifted its position in shares of Stericycle by 129.5% in the first quarter. Federated Investors Inc. PA now owns 2,088 shares of the business services provider’s stock valued at $122,000 after acquiring an additional 1,178 shares in the last quarter. Whittier Trust Co. lifted its position in shares of Stericycle by 362.6% in the second quarter. Whittier Trust Co. now owns 1,087 shares of the business services provider’s stock valued at $129,000 after acquiring an additional 852 shares in the last quarter. Dupont Capital Management Corp lifted its position in shares of Stericycle by 102.2% in the second quarter. Dupont Capital Management Corp now owns 2,089 shares of the business services provider’s stock valued at $136,000 after acquiring an additional 1,056 shares in the last quarter. NumerixS Investment Technologies Inc lifted its position in shares of Stericycle by 285.0% in the second quarter. NumerixS Investment Technologies Inc now owns 2,695 shares of the business services provider’s stock valued at $174,000 after acquiring an additional 1,995 shares in the last quarter. Finally, Intact Investment Management Inc. purchased a new stake in shares of Stericycle in the second quarter valued at $202,000. 95.46% of the stock is currently owned by institutional investors.
SRCL stock traded up $0.95 on Thursday, reaching $61.87. 1,125,655 shares of the company’s stock were exchanged, compared to its average volume of 503,050. Stericycle has a twelve month low of $56.64 and a twelve month high of $76.73. The firm has a market capitalization of $5.26 billion, a PE ratio of 13.66, a P/E/G ratio of 1.42 and a beta of 0.36. The company has a debt-to-equity ratio of 0.87, a current ratio of 0.81 and a quick ratio of 0.81.
Stericycle Company Profile
Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It collects and processes regulated and specialized waste for disposal services; and collects personal and confidential information for secure destruction, as well as offers training, consulting, recall/return, communication, and compliance services.
Further Reading: What is Compound Annual Growth Rate (CAGR)?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.